Tag: #Global Trends

The United States Food and Drug Administration (FDA) has granted formal regulatory approval to Shionogi’s antiviral medication, Xocova (ensitrelvir), specifically... Read more

Swiss pharmaceutical flagship Novartis announced Sunday that early-stage clinical data monitoring its experimental actinium-based radioligand candidate demonstrated pronounced anti-tumor activity... Read more

Healthcare conglomerate Johnson & Johnson (J&J) announced definitive clinical data from a pivotal late-stage Phase III trial showcasing that its... Read more

ZURICH (Reuters) — Swiss generic drug manufacturer Sandoz has formalized a draft anti-dumping complaint submitted to the European Commission over... Read more

U.S. pharmaceutical flagship Pfizer and Chinese drugmaker Innovent Biologics have entered into a definitive global licensing and collaboration agreement valued... Read more

Pharmaceutical flagships GSK and Ionis Pharmaceuticals have formally published positive primary data from two pivotal Phase III trials evaluating bepirovirsen,... Read more

The United States Food and Drug Administration (FDA) has granted formal regulatory approval to AstraZeneca’s PD-L1 inhibitor, Imfinzi (durvalumab), for... Read more

French biopharmaceutical flagship Sanofi announced that the U.S. Food and Drug Administration (FDA) has formally accepted the New Drug Application... Read more

Medical technology conglomerate Abbott announced on Wednesday that it has secured Europe’s CE mark for its novel Libre Duo device,... Read more